Company Overview of Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTK) for the treatment of cancer and other diseases. Its lead product candidate includes KTN3379, an antibody targeting the ErbB3 RTK, which is in Phase I clinical trials for adult patients with advanced solid tumors. The company is also developing KTN0158, a KIT RTK inhibitor for the treatment of neurofibromatosis type 1 and other inflammatory diseases; and KIT-ADC, an antibody drug conjugate for oncology treatment, as well as a range of research programs targeting RTKs. Kolltan Pharmaceuticals, Inc. was founde...
300 George Street
New Haven, CT 06511
Founded in 2007
Key Executives for Kolltan Pharmaceuticals, Inc.
Chief Executive Officer, President and Director
Co-Founder and Chairman of the Board
Co-Founder, Chairman of Scientific Advisory Board, Chief Scientist and Director
Chief Financial & Business Officer and Senior Vice President
Senior Vice President of Translational Medicine & Product Development
Compensation as of Fiscal Year 2015.
Kolltan Pharmaceuticals, Inc. Key Developments
Kolltan Pharmaceuticals Appoints Frank Karbe to its Board of Directors
Apr 13 15
Kolltan Pharmaceuticals, Inc. announced the election of Frank Karbe, former Chief Financial Officer of Exelixis, to Kolltan’s Board of Directors. Frank Karbe most recently served as Executive Vice President and Chief Financial Officer of Exelixis, where he implemented and executed financing strategies that resulted in raising over $2 billion.
Kolltan Pharmaceuticals, Inc. Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015 03:00 PM
Feb 26 15
Kolltan Pharmaceuticals, Inc. Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015 03:00 PM. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States. Speakers: Gerald McMahon, Chief Executive Officer, President and Director.
Kolltan Pharmaceuticals, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015
Jan 10 15
Kolltan Pharmaceuticals, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions